Here’s a roundup of the latest coronavirus-related news.
This week marked 300,000 coronavirus-related deaths in the United States. The current surge has proved to be the largest since the pandemic began in March, with the number of coronavirus disease 2019 (COVID-19) cases in the United States continuing to reach record highs: 242,000 cases and 114,000 COVID-19––related hospitalizations as of December 17 evening, according to The COVID Tracking Project.
Here’s a roundup of the latest coronavirus-related news:
Fauci: US Still Months Away From COVID-19 Vaccine Approval for Children
Although US health care workers have started receiving the Pfizer-BioNTech COVID -19 vaccine, vaccines for children won’t be available for “months,” according to Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
MJH COVID-19 Coalition Weighs in on Latest Pandemic News
This week, members of the MJH Life Sciences COVID-19 Coalition shared insights on the latest pandemic news, including long-term health consequences, vaccine hesitancy, and new recommendations.
New Program Rapidly Trains Pharmacy Techs in Vaccine Administration
As COVID-19 vaccine distribution is set to begin in the US, the National Pharmacy Technician Association is launching a nationally-recognized pharmacy technician administered immunization training program.
Fauci Address Pharmacists at ASHP Midyear
Despite positive news around an effective vaccine, Americans should prepare for a difficult winter ahead amid the COVID-19 pandemic, warned Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, during a session at the ASHP Midyear 2020 Clinical Meeting & Exhibition.
Generic Makers Pledge Capacity to Ensure COVID-19 Treatments in Low-, Middle-Income Countries
A group of generic drug manufacturers have pledged to work together to accelerate access to new treatments for low- and middle-income countries amid the COVID-19 pandemic with non-profit Medicines Patent Pool, according to a press release.
FDA Grants EUA to Pfizer/BioNTech COVID-19 Vaccine
The FDA has granted emergency use authorization to the Pfizer/BioNTech COVID-19 messenger RNA vaccine.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
2 Commerce Drive
Cranbury, NJ 08512